{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T17:08:08Z","timestamp":1784135288692,"version":"3.55.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["2023YFC2706100"],"award-info":[{"award-number":["2023YFC2706100"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005088","name":"Beijing Municipal Health Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005088","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009601","name":"Beijing Municipal Administration of Hospitals","doi-asserted-by":"publisher","award":["PX2023044"],"award-info":[{"award-number":["PX2023044"]}],"id":[{"id":"10.13039\/501100009601","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.thromres.2026.109730","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T15:55:58Z","timestamp":1780329358000},"page":"109730","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Rivaroxaban for pediatric venous thromboembolism in routine clinical practice: Effectiveness and safety from a real-world cohort"],"prefix":"10.1016","volume":"263","author":[{"given":"Yunyun","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumeng","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runhui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10294","key":"10.1016\/j.thromres.2026.109730_bb0005","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0140-6736(20)32658-1","article-title":"Venous thromboembolism","volume":"398","author":"Khan","year":"2021","journal-title":"Lancet"},{"issue":"22","key":"10.1016\/j.thromres.2026.109730_bb0010","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1182\/bloodadvances.2018024786","article-title":"American Society of Hematology 2018 Guidelines for management of venous thromboembolism: treatment of pediatric venous thromboembolism","volume":"2","author":"Monagle","year":"2018","journal-title":"Blood Adv."},{"issue":"5","key":"10.1016\/j.thromres.2026.109730_bb0015","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1067\/mpd.2001.118192","article-title":"Venous thromboembolism in childhood: a prospective two-year registry in The Netherlands","volume":"139","author":"Van Ommen","year":"2001","journal-title":"J. Pediatr."},{"issue":"4","key":"10.1016\/j.thromres.2026.109730_bb0020","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.jpeds.2004.06.021","article-title":"Incidence of venous thromboembolism in infants and children: data fro+m the National Hospital Discharge Survey","volume":"145","author":"Stein","year":"2004","journal-title":"J. Pediatr."},{"issue":"11","key":"10.1016\/j.thromres.2026.109730_bb0025","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1161\/ATVBAHA.114.304488","article-title":"Thrombosis: a major contributor to global disease burden","volume":"34","author":"Raskob","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.thromres.2026.109730_bb0030","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1016\/S2352-3026(19)30219-4","article-title":"Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial","volume":"7","author":"Male","year":"2020","journal-title":"Lancet Haematol."},{"key":"10.1016\/j.thromres.2026.109730_bb0035","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12959-018-0188-y","article-title":"Rivaroxaban versus standard anticoagulation for acute venous thromboembolism in childhood. Design of the EINSTEIN-Jr phase III study","volume":"16","author":"Lensing","year":"2018","journal-title":"Thromb. J."},{"issue":"12","key":"10.1016\/j.thromres.2026.109730_bb0040","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1056\/NEJMc1100734","article-title":"Oral rivaroxaban for symptomatic venous thromboembolism","volume":"364","author":"Landman","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"13","key":"10.1016\/j.thromres.2026.109730_bb0045","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1111\/1471-0528.15199","article-title":"Randomised controlled trials - the gold standard for effectiveness research: Study design: randomised controlled trials","volume":"125","author":"Hariton","year":"2018","journal-title":"BJOG"},{"issue":"4","key":"10.1016\/j.thromres.2026.109730_bb0050","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients","volume":"3","author":"Schulman","year":"2005","journal-title":"J. Thromb. Haemost."},{"issue":"11","key":"10.1016\/j.thromres.2026.109730_bb0055","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1111\/jth.13140","article-title":"Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH","volume":"13","author":"Kaatz","year":"2015","journal-title":"J. Thromb. Haemost."},{"issue":"3","key":"10.1016\/j.thromres.2026.109730_bb0060","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3109\/00016346609158455","article-title":"Menstrual blood loss--a population study. Variation at different ages and attempts to define normality","volume":"45","author":"Hallberg","year":"1966","journal-title":"Acta Obstet. Gynecol. Scand."},{"issue":"7","key":"10.1016\/j.thromres.2026.109730_bb0065","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1111\/jth.14813","article-title":"Rivaroxaban for treatment of pediatric venous thromboembolism. An Einstein-Jr phase 3 dose-exposure-response evaluation","volume":"18","author":"Young","year":"2020","journal-title":"J. Thromb. Haemost."},{"issue":"3","key":"10.1016\/j.thromres.2026.109730_bb0070","first-page":"e524","article-title":"Hospital-associated venous thromboembolism in pediatrics: a systematic review and meta-analysis of risk factors and risk-assessment models","volume":"136","author":"Min","year":"2015","journal-title":"Pediatrics"},{"key":"10.1016\/j.thromres.2026.109730_bb0075","author":"World Health Organization. (23"},{"issue":"6","key":"10.1016\/j.thromres.2026.109730_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/S2666-5247(23)00406-8","article-title":"Pneumonia outbreaks due to re-emergence of Mycoplasma pneumoniae","volume":"5","author":"Meyer Sauteur","year":"2024","journal-title":"Lancet Microbe."},{"issue":"4\u20135","key":"10.1016\/j.thromres.2026.109730_bb0085","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s12026-019-09096-6","article-title":"Monocyte subsets study in children with Mycoplasma pneumoniae pneumonia","volume":"67","author":"Wang","year":"2019","journal-title":"Immunol. Res."},{"issue":"1","key":"10.1016\/j.thromres.2026.109730_bb0090","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/irv.12501","article-title":"Excess pneumonia and influenza hospitalizations associated with influenza epidemics in Portugal from season 1998\/1999 to 2014\/2015","volume":"12","author":"Rodrigues","year":"2018","journal-title":"Influenza Other Respi. Viruses"},{"issue":"1","key":"10.1016\/j.thromres.2026.109730_bb0095","doi-asserted-by":"crossref","first-page":"24043","DOI":"10.1038\/s41598-024-74302-x","article-title":"Clinical characteristics and risk factors of pulmonary embolism with Mycoplasma pneumoniae pneumonia in children","volume":"14","author":"Zhang","year":"2024","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.thromres.2026.109730_bb0100","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1186\/s12887-023-04188-7","article-title":"A retrospective study of the clinical characteristics of 9 children with pulmonary embolism associated with Mycoplasma pneumoniae pneumonia","volume":"23","author":"Song","year":"2023","journal-title":"BMC Pediatr."},{"issue":"24","key":"10.1016\/j.thromres.2026.109730_bb0105","doi-asserted-by":"crossref","first-page":"6250","DOI":"10.1182\/bloodadvances.2020003244","article-title":"Safety and efficacy of rivaroxaban in pediatric cerebral venous thrombosis (EINSTEIN-Jr CVT)","volume":"4","author":"Connor","year":"2020","journal-title":"Blood Adv."},{"key":"10.1016\/j.thromres.2026.109730_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.thromres.2025.109397","article-title":"Comparison of rivaroxaban with warfarin for intracardiac thrombosis in the pediatric population at different cardiac sites: early experience of anticoagulation approach and treatment outcomes","volume":"253","author":"Cappelletti","year":"2025","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2026.109730_bb0115","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2018.00142","article-title":"The role of inflammation in venous thromboembolism","volume":"6","author":"Branchford","year":"2018","journal-title":"Front. Pediatr."},{"issue":"22","key":"10.1016\/j.thromres.2026.109730_bb0120","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood.V128.22.2391.2391","article-title":"Postoperative venous thromboembolism in children is increased in setting of cancer or infection","volume":"128","author":"Leraas","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2026.109730_bb0125","article-title":"Case report: Refractory Mycoplasma pneumoniae pneumonia complicated by pulmonary embolism and infarction in a child","volume":"13","author":"Zhang","year":"2025","journal-title":"Front. Pediatr."},{"issue":"1","key":"10.1016\/j.thromres.2026.109730_bb0130","doi-asserted-by":"crossref","first-page":"S1480","DOI":"10.14309\/01.ajg.0000787980.93087.ef","article-title":"S3612 a clotting and bleeding interplay in ulcerative colitis","volume":"116","author":"Jose","year":"2021","journal-title":"Am. J. Gastroenterol."},{"issue":"8","key":"10.1016\/j.thromres.2026.109730_bb0135","doi-asserted-by":"crossref","first-page":"e519","DOI":"10.1097\/MPH.0000000000001229","article-title":"Central venous catheter\u2013associated venous thromboembolism in children with hematologic malignancy","volume":"40","author":"Onyeama","year":"2018","journal-title":"J. Pediatr. Hematol. Oncol."},{"issue":"22","key":"10.1016\/j.thromres.2026.109730_bb0140","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.1182\/blood.V128.22.3817.3817","article-title":"Procoagulant profile in primary antiphospholipid syndrome is not dependent upon increased inflammatory response","volume":"128","author":"Quinteiro","year":"2016","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.thromres.2026.109730_bb0145","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1055\/s-2007-976167","article-title":"Hemostatic dysfunction in malignant hematologic disorders","volume":"33","author":"Kwaan","year":"2007","journal-title":"Semin. Thromb. Hemost."},{"issue":"3","key":"10.1016\/j.thromres.2026.109730_bb0150","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00281-022-00916-w","article-title":"Mechanisms of immunothrombosis and vasculopathy in antiphospholipid syndrome","volume":"44","author":"Knight","year":"2022","journal-title":"Semin. Immunopathol."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384826001490?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384826001490?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T16:43:31Z","timestamp":1784133811000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384826001490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":30,"alternative-id":["S0049384826001490"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2026.109730","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rivaroxaban for pediatric venous thromboembolism in routine clinical practice: Effectiveness and safety from a real-world cohort","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2026.109730","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109730"}}